|Bid||0.00 x 3000|
|Ask||0.00 x 1200|
|Day's range||73.55 - 76.34|
|52-week range||61.28 - 101.24|
|Beta (5Y monthly)||1.29|
|PE ratio (TTM)||N/A|
|Earnings date||02 Aug 2022 - 08 Aug 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||117.39|
A look at the shareholders of Sarepta Therapeutics, Inc. ( NASDAQ:SRPT ) can tell us which group is most powerful...
The FDA places Sarepta's (SRPT) next-generation DMD candidate, SRP-5051, on clinical hold, following a report of hypomagnesemia in the ongoing phase II MOMENTUM study.
Sarepta Therapeutics (SRPT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.